molecular function |
| GO:0047020 | | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | | Catalysis of the reaction: NADP+ + (5Z,13E)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate = NADPH + H+ + (5Z,13E)-9-alpha-hydroxy-11,15-dioxoprosta-5,13-dienoate. |
| GO:0052650 | | NADP-retinol dehydrogenase activity | | Catalysis of the reaction: all-trans-retinol + NADP+ = all-trans-retinal + NADPH + H+. |
| GO:0004032 | | alditol:NADP+ 1-oxidoreductase activity | | Catalysis of the reaction: an alditol + NADP+ = an aldose + NADPH + H+. |
| GO:0004033 | | aldo-keto reductase (NADP) activity | | Catalysis of the reaction: an alcohol + NADP+ = an aldehyde or a ketone + NADPH + H+. |
| GO:0047023 | | androsterone dehydrogenase activity | | Catalysis of the reaction: NAD(P)+ + androsterone = NAD(P)H + H+ + 5-alpha-androstane-3,17-dione. |
| GO:0047787 | | delta4-3-oxosteroid 5beta-reductase activity | | Catalysis of the reactions: (1) 5beta-cholestan-3-one + NADP+ = cholest-4-en-3-one + NADPH + H+ and (2) 17,21-dihydroxy-5beta-pregnane-3,11,20-trione + NADP+ = cortisone + NADPH + H+. |
| GO:0035410 | | dihydrotestosterone 17-beta-dehydrogenase activity | | Catalysis of the reaction: 5alpha-dihydrotestosterone + NAD+ = 5alpha-androstane-3,17-dione + NADH. |
| GO:0045550 | | geranylgeranyl reductase activity | | Catalysis of the formation of phytyl group from the stepwise reduction of a geranylgeranyl group. |
| GO:0047718 | | indanol dehydrogenase activity | | Catalysis of the reaction: indan-1-ol + NAD(P)+ = indanone + NAD(P)H + H+. |
| GO:0045703 | | ketoreductase activity | | Catalysis of the reduction of a ketone group to form the corresponding alcohol. |
| GO:0047086 | | ketosteroid monooxygenase activity | | Catalysis of the reaction: O2 + NADPH + progesterone = H2O + NADP+ + testosterone acetate. |
| GO:0016491 | | oxidoreductase activity | | Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced. |
| GO:0016655 | | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | | Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule. |
| GO:0018636 | | phenanthrene 9,10-monooxygenase activity | | Catalysis of the reaction: phenanthrene + O2 + NADH + H+ = H2O + NAD+ + phenanthrene-9,10-oxide. |
| GO:0036131 | | prostaglandin D2 11-ketoreductase activity | | Catalysis of the reaction: prostaglandin D2 + H+ + NADPH -> 11-epi-prostaglandin F2alpha + NADP+. |
| GO:0036130 | | prostaglandin H2 endoperoxidase reductase activity | | Catalysis of the reaction: prostaglandin H2 + NADPH + H+ -> prostaglandin F2alpha + NADP+. This reaction is the reduction of prostaglandin H2 ((5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate) to prostaglandin F2alpha ((5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate). |
| GO:0047017 | | prostaglandin-F synthase activity | | Catalysis of the reaction: NADP+ + (5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate = NADPH + H+ + (5Z,13E)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate. |
| GO:0001758 | | retinal dehydrogenase activity | | Catalysis of the reaction: retinal + NAD+ + H2O = retinoate + NADH. Acts on both 11-trans and 13-cis forms of retinal. |
| GO:0004745 | | retinol dehydrogenase activity | | Catalysis of the reaction: retinol + NAD+ = retinal + NADH + H+. |
| GO:0047045 | | testosterone 17-beta-dehydrogenase (NADP+) activity | | Catalysis of the reaction: NADP+ + testosterone = NADPH + H+ + androst-4-ene-3,17-dione. |
| GO:0047035 | | testosterone dehydrogenase (NAD+) activity | | Catalysis of the reaction: testosterone + NAD+ = androst-4-ene-3,17-dione + NADH. |
| GO:0047115 | | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | | Catalysis of the reaction: NADP+ + trans-1,2-dihydrobenzene-1,2-diol = NADPH + catechol. |
biological process |
| GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| GO:0071276 | | cellular response to cadmium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| GO:0071277 | | cellular response to calcium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| GO:0071384 | | cellular response to corticosteroid stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids. |
| GO:0071395 | | cellular response to jasmonic acid stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a jasmonic acid stimulus. |
| GO:0071799 | | cellular response to prostaglandin D stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin D stimulus. |
| GO:0071379 | | cellular response to prostaglandin stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus. |
| GO:0034614 | | cellular response to reactive oxygen species | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals. |
| GO:0009267 | | cellular response to starvation | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment. |
| GO:0019371 | | cyclooxygenase pathway | | The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2. |
| GO:0044597 | | daunorubicin metabolic process | | The chemical reactions and pathways involving daunorubicin, a chemotherapeutic of the anthracycline family that is given as a treatment for some types of cancer. |
| GO:0044598 | | doxorubicin metabolic process | | The chemical reactions and pathways involving doxorubicin, an anthracycline antibiotic, used in cancer chemotherapy. |
| GO:0016488 | | farnesol catabolic process | | The chemical reactions and pathways resulting in the breakdown of the sesquiterpenoid alcohol farnesol, 3,7,11-trimethyl-2,6,10,dodecatrien-1-ol. |
| GO:0030216 | | keratinocyte differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a keratinocyte. |
| GO:0008584 | | male gonad development | | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
| GO:0044259 | | multicellular organismal macromolecule metabolic process | | The chemical reactions and pathways involving macromolecules, large molecules including proteins, nucleic acids and carbohydrates, in multicellular organisms occurring at the tissue, organ, or organismal level. |
| GO:1900053 | | negative regulation of retinoic acid biosynthetic process | | Any process that stops, prevents or reduces the frequency, rate or extent of retinoic acid biosynthetic process. |
| GO:0055114 | | oxidation-reduction process | | A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons. |
| GO:0010942 | | positive regulation of cell death | | Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:2000353 | | positive regulation of endothelial cell apoptotic process | | Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process. |
| GO:0051897 | | positive regulation of protein kinase B signaling | | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| GO:2000379 | | positive regulation of reactive oxygen species metabolic process | | Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
| GO:0042448 | | progesterone metabolic process | | The chemical reactions and pathways involving progesterone, a steroid hormone produced in the ovary which prepares and maintains the uterus for pregnancy. Also found in plants. |
| GO:0006693 | | prostaglandin metabolic process | | The chemical reactions and pathways involving prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring due to the formation of a bond between two carbons of a fatty acid. They have a wide range of biological activities. |
| GO:0000060 | | protein import into nucleus, translocation | | A protein transport process that contributes to protein import into the nucleus, and that results in the vectorial transfer of a cargo-carrier protein complex through the nuclear pore complex from the cytoplasmic side to the nucleoplasmic side of the nuclear envelope. |
| GO:0048385 | | regulation of retinoic acid receptor signaling pathway | | Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity. |
| GO:2000224 | | regulation of testosterone biosynthetic process | | Any process that modulates the frequency, rate or extent of testosterone biosynthetic process. |
| GO:0070293 | | renal absorption | | A renal system process in which water, ions, glucose and proteins are taken up from the collecting ducts, glomerulus and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures (e.g. protein absorption is observed in nephrocytes in Drosophila, see PMID:23264686). |
| GO:0007584 | | response to nutrient | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
| GO:0042574 | | retinal metabolic process | | The chemical reactions and pathways involving retinal, a compound that plays an important role in the visual process in most vertebrates. In the retina, retinal combines with opsins to form visual pigments. Retinal is one of the forms of vitamin A. |
| GO:0001523 | | retinoid metabolic process | | The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity. |
| GO:0042572 | | retinol metabolic process | | The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A. |
| GO:0008202 | | steroid metabolic process | | The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. |
| GO:0061370 | | testosterone biosynthetic process | | The chemical reactions and pathways resulting in the formation of testosterone, an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4 C-5. |
cellular component |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |